Reevaluation of optimal initial dose of rocuronium

Reevaluation of optimal initial dose of rocuronium - Reevaluation of optimal initial dose of rocuronium

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007289

Enrollment

300

Registered

2012-02-14

Start date

2012-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General anesthesia case

Interventions

sevoflurane anesthesia + 0.3mg/kg of rocuronium sevoflurane anesthesia + 0.6mg/kg of rocuronium sevoflurane anesthesia + 0.9mg/kg of rocuronium propofol anesthesia + 0.3mg/kg of rocuronium propofo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ASA1-2, General anesthesia cases

Exclusion criteria

Exclusion criteria: Hepatic or Renal function disorder, BMI>30, history of neuromuscular disease, allergy

Design outcomes

Primary

Measure	Time frame
Train of four, ease of intubation	—

Countries

Japan,Asia(except Japan)

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026